Literature DB >> 15143236

MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.

Mukesh G Harisinghani1, W Thomas Dixon, Mansi A Saksena, Elena Brachtel, Daniel J Blezek, Paritosh J Dhawale, Maha Torabi, Peter F Hahn.   

Abstract

Detection of local or regional metastases to lymph nodes is clinically important in virtually any type of primary tumor. Current imaging techniques rely heavily on the size criterion for characterization of nodal disease. However, size can be an ineffective parameter for diagnosis of tumor spread to lymph nodes. Magnetic resonance (MR) imaging performed before and after administration of ferumoxtran-10 is a promising technique for characterization of lymph nodes in patients with various primary tumors. Normal homogeneous uptake of ferumoxtran-10 in nonmetastatic nodes shortens the T2 and T2*, turning these nodes dark, whereas malignant nodes lack uptake and remain hyperintense. To optimize acquisition strategies, the following factors should be considered: the timing of contrast material-enhanced imaging, the section thickness, the imaging plane, and the imaging parameters for T2*-weighted sequences. In addition, MR imaging with ferumoxtran-10 allows presurgical mapping of lymph nodes and quantitative estimation of T2*. Copyright RSNA, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143236     DOI: 10.1148/rg.243035190

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  21 in total

Review 1.  Preclinical lymphatic imaging.

Authors:  Fan Zhang; Gang Niu; Guangming Lu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

Review 2.  Magnetic resonance molecular imaging with nanoparticles.

Authors:  Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Anne M Morawski; Anne H Schmieder; Katherine C Crowder; Samuel A Wickline
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

Review 3.  New imaging modalities in bladder cancer.

Authors:  Mansi A Saksena; Douglas M Dahl; Mukesh G Harisinghani
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

4.  Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo.

Authors:  Chengli Yang; Antonina Rait; Kathleen F Pirollo; John A Dagata; Natalia Farkas; Esther H Chang
Journal:  Nanomedicine       Date:  2008-07-26       Impact factor: 5.307

Review 5.  Incorporating new imaging models in breast cancer management.

Authors:  Denise H Reddy; Ellen B Mendelson
Journal:  Curr Treat Options Oncol       Date:  2005-03

Review 6.  Imaging of distant metastases of prostate cancer.

Authors:  Filippo Pesapane; Marcin Czarniecki; Matteo Basilio Suter; Baris Turkbey; Geert Villeirs
Journal:  Med Oncol       Date:  2018-09-14       Impact factor: 3.064

Review 7.  Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors.

Authors:  Samdeep K Mouli; Lee C Zhao; Reed A Omary; C Shad Thaxton
Journal:  Nat Rev Urol       Date:  2010-01-19       Impact factor: 14.432

8.  In vivo assessment of experimental neonatal excitotoxic brain lesion with USPIO-enhanced MR imaging.

Authors:  Marianne Alison; Robin Azoulay; François Chalard; Pierre Gressens; Guy Sebag
Journal:  Eur Radiol       Date:  2010-09       Impact factor: 5.315

Review 9.  Contrast-enhanced MR imaging of lymph nodes in cancer patients.

Authors:  Seung Hong Choi; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

10.  Imaging in primary penile cancer: current status and future directions.

Authors:  Rohit Kochhar; Ben Taylor; Vijay Sangar
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.